PresentationSIK

Discovery of a novel, selective SIK3 inhibitor

October 6, 2025

UEG Week 2025 October 6, Berlin

Discovery of a novel, selective SIK3 inhibitor for the treatment of ulcerative colitis, Crohn’s disease and other autoimmune diseases